Early research (Phase 1)Active Not RecruitingNCT02381886
What this trial is testing
IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Who this might be right for
Advanced Malignancies That Harbor IDHR132 Mutations
Novartis Pharmaceuticals 166